Dr. Thomas A. Haldis, DO

Dr. Haldis practices at Sanford Fargo Hospice in Fargo, North Dakota.

Dr. Haldis' NPI, 1588681449, was assigned on July 16, 2006. Dr. Haldis graduated from Pennsylvania State University College of Medicine in 1998. Dr. Haldis holds North Dakota license 10088.

Dr. Haldis' primary practice is Sanford Fargo Hospice, at 801 Broadway North, Fargo, ND 58102 in Cass County. The practice phone is (701) 234-7550.

Dr. Haldis' primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Dr. Haldis is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Haldis to 4 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haldis practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Haldis' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Haldis' licenses on file in 2 states: North Dakota and Wisconsin.

CMS data shows 1,807 Medicare services from Dr. Haldis across 22 procedure codes in 2024, for 634 Medicare patients. Medicare paid $210,899 for them.

CMS counts 634 Medicare patients who saw Dr. Haldis in 2024. The largest group is 75 to 84, with 272 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haldis' median patient age at 78, with 42% women.

In 2024, Dr. Haldis wrote 1,040 Medicare Part D claims for 259 patients. 87% of them were for generic drugs. CMS names the drug for 949 of them, across 21 drugs with 11 or more claims each, at $97,054 in total drug cost. In 2023, CMS named 1,047 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Haldis for performance year 2024, reported as part of a group. Dr. Haldis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 54 procedures of coronary angioplasty and stenting by Dr. Haldis, more than 86% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Haldis, published from 2011 to 2024. 2017 was the busiest year, with 2. The most frequent topics are Aortic Valve Stenosis, Predictive Value of Tests and Stroke. Dr. Haldis has published most often in Catheter Cardiovasc Interv. Dr. Haldis' most frequent co-authors are Cornelius McKown Dyke, MD, Hunter Thoroughgood Row, MD and Stefan Christian Bertog, MD.

Dmand AI links Dr. Haldis to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Tricuspid Valve Insufficiency, Ventricular Outflow Obstruction and Aortic Valve Stenosis.

CMS Open Payments shows 414 general payments to Dr. Haldis from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. AstraZeneca Pharmaceuticals LP paid the most, $59,896.

Dr. Haldis graduated from Pennsylvania State University College of Medicine in 1998.